Salivary Soluble CD40 Ligand Levels and Their Relationship to Periodontal Markers in Patients with Periodontitis and/or Obesity: An Observational Case-Control Study

Authors

  • Muthana Sameer Hasan College of Dentistry, University of Baghdad, Baghdad, Iraq https://orcid.org/0009-0001-9036-0987
  • Suzan Ali Salman Department of Periodontics, College of Dentistry, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.54133/ajms.v5i.174

Keywords:

Obesity, Periodontitis, Saliva, sCD40L

Abstract

Background: sCD40L, a co-stimulatory molecule that activates T-helper cells, is one of many mediators that regulate the inflammatory conditions of periodontitis and obesity. Additionally, the association of this biomarker with periodontitis and obesity has not been robustly investigated. Objective: Evaluation of salivary levels of sCD40L in periodontitis and obese patients in comparison to healthy controls and their association with different periodontal parameters. Methods: 110 subjects were enrolled in this study. Salivary samples were obtained prior to the clinical examination. They were divided into four groups: the first group (20 subjects) was the control group; the second group (30 subjects) consisted of subjects with obesity (BMI≥30 kg/m2); the third group (30 subjects) consisted of subjects with periodontitis; and the fourth group (30 subjects) consisted of subjects with periodontitis and obesity. A periodontal examination was performed to report plaque index (PLI), bleeding on probing (BOP), probing pocket depth (PPD), and clinical attachment loss (CAL). Obesity was assessed using the body mass index (BMI). Results: Both periodontitis and obese patients demonstrated elevated salivary sCD40L levels compared to healthy subjects. sCD40L was positively correlated with PLI in periodontitis patients and with PPD in obese periodontitis patients. Conclusions: A significant association between sCD40L, periodontitis, and obesity was reported, implicating sCD40L's role in the pathogenesis of these conditions.

Downloads

Download data is not yet available.

References

Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89 (Suppl 1):S173-S182. doi: 10.1002/JPER.17-0721. DOI: https://doi.org/10.1002/JPER.17-0721

Silva N, Abusleme L, Bravo D, Dutzan N, Garcia-Sesnich J, Vernal R, Hernández M, Gamonal J. Host response mechanisms in periodontal diseases. J Appl Oral Sci. 2015;23(3):329-355. doi: 10.1590/1678-775720140259. DOI: https://doi.org/10.1590/1678-775720140259

Bullon P, Newman HN, Battino M. Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction? Periodontol. 2000. 2014;64(1):139-153. doi: 10.1111/j.1600-0757.2012.00455.x. DOI: https://doi.org/10.1111/j.1600-0757.2012.00455.x

Franco R, Barlattani A, Perrone MA, Basili M, Miranda M, Costacurta M, et al. Obesity, bariatric surgery and periodontal disease: a literature update. Eur Rev Med Pharmacol Sci. 2020;24(9):5036-5045. doi: 10.26355/eurrev_202005_21196.

Abas D, Eqbal G, Prevalence of obesity among adolescents at secondary schools in Kirkuk city. Iraqi Nat J Nurs Specialties. 2018;26:96-101. doi: 10.58897/injns.v26i2.175.

Jasim HM, Abdul Hussein HM, Al-Kaseer EA. Obesity among females in Al-Sader city Baghdad, Iraq, 2017. J Faculty Med Baghdad. 2018;60(2):105-107. DOI: https://doi.org/10.32007/19jfacmedbaghdad36.v60i2.15

Martinez-Herrera M, Silvestre-Rangil J, Silvestre FJ. Association between obesity and periodontal disease. A systematic review of epidemiological studies and controlled clinical trials. Med Oral Patol Oral Cir Bucal. 2017;22(6):e708-e715. doi: 10.4317/medoral.21786. DOI: https://doi.org/10.4317/medoral.21786

Nascimento GG, Leite FR, Do LG, Peres KG, Correa MB, Demarco FF, et al. Is weight gain associated with the incidence of periodontitis? A systematic review and meta-analysis. J Clin Periodontol. 2015;42(6):495-505. doi: 10.1111/jcpe.12417. DOI: https://doi.org/10.1111/jcpe.12417

Pataro AL, Costa FO, Cortelli SC, Cortelli JR, Abreu MH, Costa JE. Association between severity of body mass index and periodontal condition in women. Clin Oral Investig. 2012;16(3):727-734. doi: 10.1007/s00784-011-0554-7. DOI: https://doi.org/10.1007/s00784-011-0554-7

Suvan J, Petrie A, Moles DR, Nibali L, Patel K, Darbar U, et al. Body mass index as a predictive factor of periodontal therapy outcomes. J Dent Res. 2014;93(1):49-54. doi: 10.1177/0022034513511084. DOI: https://doi.org/10.1177/0022034513511084

Gul SS, Imran NK, Al-Sharqi AJB, Abdulkareem AA. Association of overweight/obesity with the severity of periodontitis using BPE code in an Iraqi population. Clin Epidemiol Global Health. 2020;9. doi: 10.1016/j.cegh.2020.06.005. DOI: https://doi.org/10.1016/j.cegh.2020.06.005

Ismail H, Mahmood M. Effect of melatonin supplementation on the gingival health and lipid profiles in obese periodontitis patients. J Baghdad Coll Dentistry. 2022;34:51-59. DOI: https://doi.org/10.26477/jbcd.v34i1.3092

Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145(5):2273-2282. doi: 10.1210/en.2003-1336. DOI: https://doi.org/10.1210/en.2003-1336

Ameen EM, Mohammed HY. Correlation between tumor necrosis factor–alfa and anti-tyrosine phosphatase with obesity and diabetes type 2. Iraqi J Sci. 2022;63(8):3322-3331. doi: 10.24996/ijs.2022.63.8.7. DOI: https://doi.org/10.24996/ijs.2022.63.8.7

Yamazaki K, Yoshie H, Seymour GJ. T cell regulation of the immune response to infection in periodontal diseases. Histol Histopathol. 2003;18(3):889-896. doi: 10.14670/HH-18.889.

Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998;16:111-35. doi: 10.1146/annurev.immunol.16.1.111. DOI: https://doi.org/10.1146/annurev.immunol.16.1.111

Chaturvedi R, Gupta M, Jain A, Das T, Prashar S. Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease. Clin Oral Investig. 2015;19(1):45-52. doi: 10.1007/s00784-014-1216-3. DOI: https://doi.org/10.1007/s00784-014-1216-3

Freedman JE. CD40-CD40L and platelet function: beyond hemostasis. Circ Res. 2003;92(9):944-946. doi: 10.1161/01.RES.0000074030.98009.FF. DOI: https://doi.org/10.1161/01.RES.0000074030.98009.FF

Tenovuo J, Lagerlof F, (Eds.), Textbook of clinical cardiology, (2nd ed.), 1994, Munksgaard Copenhagen: Munksgaard Copenhagen. 1994;17-43.

Nuttall FQ. Body mass index: Obesity, BMI, and health: A critical review. Nutr Today. 2015;50(3):117-128. doi: 10.1097/NT.0000000000000092. DOI: https://doi.org/10.1097/NT.0000000000000092

Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159-S172. doi: 10.1002/JPER.18-0006. DOI: https://doi.org/10.1002/JPER.18-0006

Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89(Suppl 1):S74-S84. doi: 10.1002/JPER.17-0719. DOI: https://doi.org/10.1002/JPER.17-0719

Papapanagiotou D, Nicu EA, Bizzarro S, Gerdes VE, Meijers JC, Nieuwland R, et al. Periodontitis is associated with platelet activation. Atherosclerosis. 2009;202(2):605-611. doi: 10.1016/j.atherosclerosis.2008.05.035. DOI: https://doi.org/10.1016/j.atherosclerosis.2008.05.035

Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva MC, de Souza AM, Faccioli LH, et al. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol. 2009;80(4):594-602. doi: 10.1902/jop.2009.080561. DOI: https://doi.org/10.1902/jop.2009.080561

Schönbeck U, Mach F, Libby P. CD154 (CD40 ligand). Int J Biochem Cell Biol. 2000;32(7):687-693. doi: 10.1016/s1357-2725(00)00016-9. DOI: https://doi.org/10.1016/S1357-2725(00)00016-9

Zhou L, Stordeur P, de Lavareille A, Thielemans K, Capel P, Goldman M, et al. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity. Thromb Haemost. 1998;79(5):1025-1028. DOI: https://doi.org/10.1055/s-0037-1615114

Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res. 2007;86(4):306-319. doi: 10.1177/154405910708600403. DOI: https://doi.org/10.1177/154405910708600403

Schönbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res. 1997;81(3):448-454. doi: 10.1161/01.res.81.3.448. DOI: https://doi.org/10.1161/01.RES.81.3.448

Alhashimi N, Frithiof L, Brudvik P, Bakhiet M. CD40-CD40L expression during orthodontic tooth movement in rats. Angle Orthod. 2004;74(1):100-105. doi: 10.1043/0003-3219(2004)074<0100:CEDOTM>2.0.CO;2.

Sempowski GD, Chess PR, Moretti AJ, Padilla J, Phipps RP, Blieden TM. CD40 mediated activation of gingival and periodontal ligament fibroblasts. J Periodontol. 1997;68(3):284-292. doi: 10.1902/jop.1997.68.3.284. DOI: https://doi.org/10.1902/jop.1997.68.3.284

Recker EN, Brogden KA, Avila-Ortiz G, Fischer CL, Pagan-Rivera K, Dawson DV, et al. Novel biomarkers of periodontitis and/or obesity in saliva-An exploratory analysis. Arch Oral Biol. 2015;60(10):1503-1509. doi: 10.1016/j.archoralbio.2015.07.006. DOI: https://doi.org/10.1016/j.archoralbio.2015.07.006

Wassenaar A, Verschoor T, Kievits F, Den Hartog MT, Kapsenberg ML, Everts V, et al. CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts. Clin Exp Immunol. 1999;115(1):161-167. doi: 10.1046/j.1365-2249.1999.00764.x. DOI: https://doi.org/10.1046/j.1365-2249.1999.00764.x

Herzberg MC, Weyer MW. Dental plaque, platelets, and cardiovascular diseases. Ann Periodontol. 1998;3(1):151-160. doi: 10.1902/annals.1998.3.1.151. DOI: https://doi.org/10.1902/annals.1998.3.1.151

André P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation. 2002 Aug 20;106(8):896-9. doi: 10.1161/01.cir.0000028962.04520.01. DOI: https://doi.org/10.1161/01.CIR.0000028962.04520.01

Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Sisman AR, Yuksel F, et al. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res. 2010;8(2):89-95. doi: 10.3121/cmr.2010.889. DOI: https://doi.org/10.3121/cmr.2010.889

Wakai K, Kawamura T, Umemura O, Hara Y, Machida J, Anno T, et al. Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol. 1999;26(10):664-672. doi: 10.1034/j.1600-051x.1999.261006.x. DOI: https://doi.org/10.1034/j.1600-051X.1999.261006.x

Christan C, Dietrich T, Hägewald S, Kage A, Bernimoulin JP. White blood cell count in generalized aggressive periodontitis after non-surgical therapy. J Clin Periodontol. 2002 Mar;29(3):201-6. doi: 10.1034/j.1600-051x.2002.290303.x. DOI: https://doi.org/10.1034/j.1600-051x.2002.290303.x

Guldiken S, Demir M, Arikan E, Turgut B, Azcan S, Gerenli M, et al. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res. 2007;119(1):79-84. doi: 10.1016/j.thromres.2005.12.019. DOI: https://doi.org/10.1016/j.thromres.2005.12.019

Desideri G, Ferri C. Effects of obesity and weight loss on soluble CD40L levels. JAMA. 2003;289(14):1781-1782. doi: 10.1001/jama.289.14.1781. DOI: https://doi.org/10.1001/jama.289.14.1781

Schernthaner GH, Kopp HP, Krzyzanowska K, Kriwanek S, Koppensteiner R, Schernthaner G. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. Eur J Clin Invest. 2006;36(6):395-401. doi: 10.1111/j.1365-2362.2006.01649.x. DOI: https://doi.org/10.1111/j.1365-2362.2006.01649.x

Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752-61. doi: 10.1172/JCI21625. DOI: https://doi.org/10.1172/JCI21625

Davì G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288(16):2008-2014. doi: 10.1001/jama.288.16.2008. DOI: https://doi.org/10.1001/jama.288.16.2008

Lehmann AP, Nijakowski K, Swora-Cwynar E, Łuczak J, Czepulis N, Surdacka A. Characteristics of salivary inflammation in obesity. Pol Arch Intern Med. 2020;130(4):297-303. doi: 10.20452/pamw. DOI: https://doi.org/10.20452/pamw.15186

Downloads

Published

2023-08-09

How to Cite

Hasan, M. S., & Salman, S. A. (2023). Salivary Soluble CD40 Ligand Levels and Their Relationship to Periodontal Markers in Patients with Periodontitis and/or Obesity: An Observational Case-Control Study. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 5, 127–133. https://doi.org/10.54133/ajms.v5i.174

Issue

Section

Original article

Similar Articles

You may also start an advanced similarity search for this article.